Archive for May, 2010
Herb and Honey Inc. of Ridgefield, NJ, is recalling its 16 ounce packages of “Dried Apricots” (Product of Turkey) because they contain undeclared sulfites. Consumers who have a severe sensitivity to sulfites run the risk of serious or life-threatening allergic reactions if they consume this product…
Tags: food allergy
Voluntary recall of all manufactured lots has been initiated as a precautionary measure due to instances of particulate matter observed in a limited number of vials during routine stability testing.
Tags: MedWatch Safety Alerts
So Shing Hing (USA) Trading Co Ltd is recalling DRIED MELON because the product was found to contain undeclared sulfites. Consumers who have severe sensitivity to sulfites run the risk of serious or life-threatening allergic reactions if they consume this product. The recalled DRIED MELON was distributed in NYC Metro Area in 10 oz. clear plastic bags, with item number 520 and bar code number 4893230928048. The DRIED MELON is a product of China
Tags: FDA Recalls
The U.S. Food and Drug Administration today advised consumers and health care professionals about potential rare occurrences of severe liver injury in patients taking the weight-loss medication orlistat, marketed as Xenical and Alli.
Tags: fda press release
Revised labeling to include cases of severe liver injury.
Tags: MedWatch Safety Alerts
People who take Xenical or Alli need to be aware of the rare occurrence of severe liver injury reported in some individuals who take these weight-loss drugs.
Tags: Consumer Health Alerts
FDA Announces Collaboration with Drugs.com
Tags: fda press release
Stephen P. Sinnott, United States Attorney for the Western District of Wisconsin, announced that Beehive Botanicals, Inc. (“Beehive”) assented to the entry of a consent decree of condemnation and injunction, agreeing to forfeit certain bee-derived products and components to the United States. The products and components were seized from Beehive’s facility in Hayward, Wis.
Tags: fda press release
The U.S. Food and Drug Administration today warned consumers and health care professionals about a possible increased risk of fractures of the hip, wrist, and spine with high doses or long-term use of a class of medications called proton pump inhibitors. The product labeling will be changed to describe this possible increased risk.
Tags: fda press release